Intracellular mechanisms of amyloid β-peptide Aβ25-35 induced neurite outgrowth inhibition in vitro

Alzheimer's Reports

Volumn 1, Issue 1, 1998, Pages 55-60

  Larner, Andrew J ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007178807     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bandtlow CE, Schmidt MF, Hassinger TD et al., (1993). Role of intracellular calcium in NI-35-evoked collapse of neuronal growth cones. Science 259, 80-83.
2. Barker R (1991). Substance P and neurodegenerative disorders. A speculative review. Neuropeptides 20, 73-78.
3. Behl C, Davis J, Cole GM and Schubert D (1992). Vitamin E protects nerve cells from amyloid βprotein toxicity. Biochem Biophys ResCommun 186, 944-950.
4. Behl C, Davis JB, Klier FG and Schubert D (1994a). Amyloid β peptide induces necrosis rather than apoptosis. Brain Res 645, 253-264.
5. Behl C, Davis JB, Lesley R and Schubert D (1994b). Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
6. Eckert A, Forstl H, Hartmann H et al., (1995). The amplifying effect of β-amyloid on cellular calcium signalling is reduced in Alzheimer's disease. NeuroReport 6, 1199-1202.
7. Gowing E, Roher AE, Woods AS et al., (1994). Chemical characterization of Aβ17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 269, 10987-10990.
8. Hartmann H, Eckert A and Muller WE (1993). β-amyloid protein amplifies calcium signalling in central neurons from the adult mouse. Biochem Biophys Res Commun 194, 1216-1220.
9. Joseph R and Han E (1992). Amyloid β protein fragment 25-35 causes activation of cytoplasmic calcium in neurons. Biochem Biophys Res Commun 184, 1441-1447.
10. Larner AJ (1995a). The cortical neuritic dystrophy of Alzheimer's disease: nature, significance, and possible pathogenesis. Dementia 6, 218-224.
11. Larner AJ (1995b). Hypothesis: physiological and pathological interrelationships of amyloid β peptide and the amyloid precursor protein. BioEssays 17, 819-824.
12. Larner AJ (1996). Neurite growth-inhibitory molecules in Alzheimer's disease brain J Neurol Neurosurg Psychiatry 61, 222.
13. Lamer AJ (1997a). Neurite growth-inhibitory properties of amyloid β-peptides in vitro: Aβ25-35, but not Aβ1-40, is inhibitory. Neurosci Res Commun 20, 147-155.
14. Lamer AJ (1997b). The pathogenesis of Alzheimer's disease: an alternative to the amyloid hypothesis. J Neuropathol Exper Neurol 56, 214-215.
15. Mattson MP, Cheng B, Davis D et al., (1992). β amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12, 376-389.
16. Morris RG (1996). Neurobiological correlates of cognitive dysfunction. In: Morris RG, ed. The Cognitive Neuropsychology of Alzheimer-type Dementia. Oxford, Oxford University Press, pp 223-254.
17. Narumi S and Fujita T (1978). Stimulatory effects of substance P and nerve growth factor on neurite outgrowth in embryonic dorsal root ganglia. Neuropharmacol 17, 73-76.
18. Rush DK, Aschmies S and Merriman MC (1992). Intracerebral β-amyloid (25-35) produces tissue damage. Is it neurotoxic? Neurobiol Aging 13, 591-594.
19. Shearman MS, Ragan CI and Iversen LL (1994). Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc Natl Acad Sci USA 91, 1470-1474.
20. Simmons MA and Schneider CR (1993). Amyloid β peptides act directly on single neurons. Neurosci Lett 150, 133-136.
21. Tabaton M, Nunzi MG, Xue R et al., (1994). Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun 200, 1598-1603.
22. 2+channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J Neurochem 62, 372-375.
23. Whitson JS and Appel SH (1995). Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade. Neurobiol Aging 16, 5-10.
24. Woods AG, Cribbs DH, Whittemore ER and Cotman CW (1995). Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate β-amyloid (25-35) induced neurodegeneration in cultured hippocampal neurons. Brain Res. 697, 53-62.
25. Yankner BA, Duffy LK and Kirschner DA (1990). Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282.
26. Zimprich F and Bolsover SR (1996). Calcium channels in neuroblastoma cell growth cones. Eur J Neurosci 8, 467-475.